Association Between Changes in Skeletal Muscle Quality and Prognosis in Postoperative Patients with Early Gastric Cancer
Annals of Surgical Oncology · 2024
DOI: 10.1245/s10434-024-16012-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Surgical Oncology, 2024. Verfasst von Shiho Kobayashi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Toranomon Hospital, Minato-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Gastrectomy, Muscle, Skeletal, Tomography, X-Ray Computed. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Identifying accurate prognostic factors is crucial for postoperative management of early gastric cancer (EGC) patients. Skeletal muscle quality (SMQ), defined by muscle density on computed tomography (CT) images, has been proposed as a novel prognostic factor. This study compared the prognostic significance of SMQ changes with the well-established factor of body weight (BW) loss in the postoperative EGC setting. METHODS: This single-center retrospective study included 297 postoperative EGC patients (median age 69 years, 68.4% male) who had preoperative and 1-year-postoperative gastrectomy CT images. SMQ was defined as the modified intramuscular adipose tissue content (mIMAC = skeletal muscle density-subcutaneous fat density on CT images) and the change as ΔmIMAC. Log-rank test, Kaplan-Meier survival, and Cox proportional hazards regression analyses were used to assess the associations between prognosis and either ΔmIMAC or BW change (ΔBW). Prognosis prediction by ΔmIMAC and ΔBW was compared by using the area under the curve (AUC) of the receiver operating characteristic curve. RESULTS: ΔmIMAC was significantly associated with prognosis (log-rank test; P = 0.037), but ΔBW was not (P = 0.243). Prognosis was significantly poorer in the severely decreased mIMAC group than in the preserved group (multivariate Cox proportional hazards regression analysis; P = 0.030) but was unaffected by BW changes (P = 0.697). The AUC indicated a higher prognostic value for ΔmIMAC than ΔBW (ΔmIMAC: AUC = 0.697, ΔBW: AUC = 0.542). CONCLUSIONS: One-year post-gastrectomy SMQ changes may be better prognostic EGC predictors than BW changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation, Toranomon Hospital, Minato-ku, Tokyo, Japan.
- Department of Rehabilitation Sciences, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa, Japan.
- Department of Rehabilitation Sciences, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa, Japan. k-kamiya@kitasato-u.ac.jp.
- Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Kanagawa, Japan. k-kamiya@kitasato-u.ac.jp.
- Division of Research, ARCE Inc., Sagamihara, Kanagawa, Japan.
- Department of Cardiovascular Rehabilitation, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Zitieren
APA
Kobayashi, S., Kamiya, K., Miki, T., Yamashita, M., Noda, T., Ueno, K., Hotta, K., Sakuraya, M., Niihara, M., Fukuda, M., & Hiki, N. (2024). Association Between Changes in Skeletal Muscle Quality and Prognosis in Postoperative Patients with Early Gastric Cancer. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-024-16012-2
Vancouver
Kobayashi S, Kamiya K, Miki T, Yamashita M, Noda T, Ueno K, et al. Association Between Changes in Skeletal Muscle Quality and Prognosis in Postoperative Patients with Early Gastric Cancer. Annals of Surgical Oncology. 2024. doi:10.1245/s10434-024-16012-2
BibTeX
@article{Kobayashi2024,
author = {Kobayashi, Shiho and Kamiya, Kentaro and Miki, Takashi and Yamashita, Masashi and Noda, Takumi and Ueno, Kensuke and Hotta, Kazuki and Sakuraya, Mikiko and Niihara, Masahiro and Fukuda, Michinari and Hiki, Naoki},
title = {Association Between Changes in Skeletal Muscle Quality and Prognosis in Postoperative Patients with Early Gastric Cancer},
journal = {Annals of Surgical Oncology},
year = {2024},
doi = {10.1245/s10434-024-16012-2}
}
EUVIMED